恆指跌幅擴至逾300點考驗15,900 碧服、龍湖及京東健康挫逾5%-7%
恆指在權重新經濟股及金融股主導跌幅擴至312點或1.9%報15,903、創逾14個月低,總成交額386億元。
藍籌股幾乎全面向下,京東健康(06618.HK)沽壓最大,股價挫逾7%報29.85元創上市新低。
地產股及內房物管股以龍湖(00960.HK)沽壓最大,股價連跌第七天,最低見9.47元,創逾14個月低,現報9.48元,續挫6.9%;碧服(06098.HK)及華潤萬象(01209.HK)跌逾5%及4%,報5.51元及23.8元。
金融股以匯控(00005.HK)及港交所(00388.HK)沽壓最大,股價跌近3%,報59.25元及244.8元。友邦(01299.HK)扭三連升,股價反覆回吐1.5%報63.85元;中國平安(02318.HK)回吐2.1%報32元。
內需股潤啤(00291.HK)、安踏(02020.HK)、蒙牛(02319.HK)、李寧(02331.HK)、百威亞太(01876.HK)及康師傅(00322.HK)跌逾2%-5%,後兩者最傷,股價齊尋底,分別報12.4元及8.02元,續跌逾4%-5%元。
權重新經濟股騰訊(00700.HK)、阿里(09988.HK)、京東(09618.HK)及美團(03690.HK)跌逾2%-3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.